Menu Search
Equities

Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS

TNZTP.E:IST

Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS

Actions
Health CareHealth Care Providers
  • Price (TRY)57.35
  • Today's Change-1.35 / -2.30%
  • Shares traded405.82k
  • 1 Year change+169.76%
  • Beta--
Data delayed at least 15 minutes, as of May 21 2024 16:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS is a Turkey-based company, which provides health and education services as it serves as an outpatient diagnosis and treatment center with a surgical unit and 25 beds. Tapdi Oksijen Private Health and Education Services provides health services at Tapdi Buca Medical Center and IS09001-2000, ISO9001:2008 Quality Management Certificate and TSE-ISO 10002 with its organizations titled Tinaztepe Hospital. It continues with Customer Satisfaction Management System Certificates. United States accreditation board Joint Accreditation procedures were completed with Commission International (JCI) and the Company received the certificate in 2017.

  • Revenue in TRY (TTM)1.31bn
  • Net income in TRY822.72m
  • Incorporated2004
  • Employees1.03k
  • Location
    Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret ASKosu Yolu Caddesi No: 2 506 Sk. SirinyerBucaIZMIR TurkeyTUR
  • Phone+90 2 324541414
  • Fax+90 2 324404422
  • Websitehttps://tinaztepe.com/
More ▼

Institutional shareholders

0.93%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 31 Dec 20231.19m0.93%
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.